Literature DB >> 27777976

Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.

Lisa R Young1,2,3, Peter M Gulleman1, Chelsi W Short1, Harikrishna Tanjore2, Taylor Sherrill2, Aidong Qi1, Andrew P McBride1, Rinat Zaynagetdinov2, John T Benjamin4, William E Lawson2, Sergey V Novitskiy2, Timothy S Blackwell2,3,5.   

Abstract

Alveolar epithelial cell (AEC) dysfunction underlies the pathogenesis of pulmonary fibrosis in Hermansky-Pudlak syndrome (HPS) and other genetic syndromes associated with interstitial lung disease; however, mechanisms linking AEC dysfunction and fibrotic remodeling are incompletely understood. Since increased macrophage recruitment precedes pulmonary fibrosis in HPS, we investigated whether crosstalk between AECs and macrophages determines fibrotic susceptibility. We found that AECs from HPS mice produce excessive MCP-1, which was associated with increased macrophages in the lungs of unchallenged HPS mice. Blocking MCP-1/CCR2 signaling in HPS mice with genetic deficiency of CCR2 or targeted deletion of MCP-1 in AECs normalized macrophage recruitment, decreased AEC apoptosis, and reduced lung fibrosis in these mice following treatment with low-dose bleomycin. We observed increased TGF-β production by HPS macrophages, which was eliminated by CCR2 deletion. Selective deletion of TGF-β in myeloid cells or of TGF-β signaling in AECs through deletion of TGFBR2 protected HPS mice from AEC apoptosis and bleomycin-induced fibrosis. Together, these data reveal a feedback loop in which increased MCP-1 production by dysfunctional AECs results in recruitment and activation of lung macrophages that produce TGF-β, thus amplifying the fibrotic cascade through AEC apoptosis and stimulation of fibrotic remodeling.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27777976      PMCID: PMC5070955          DOI: 10.1172/jci.insight.88947

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  49 in total

1.  Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.

Authors:  Bernadette R Gochuico; Marjan Huizing; Gretchen A Golas; Charles D Scher; Maria Tsokos; Stacey D Denver; Melissa J Frei-Jones; William A Gahl
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

2.  TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.

Authors:  Lynne A Murray; Qingsheng Chen; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Xueyang Peng; Mridu Gulati; Robert J Homer; Thomas Russell; Nico van Rooijen; Jack A Elias; Cory M Hogaboam; Erica L Herzog
Journal:  Int J Biochem Cell Biol       Date:  2010-10-29       Impact factor: 5.085

3.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

4.  Genomic structure of the mouse Ap3b1 gene in normal and pearl mice.

Authors:  L Feng; B W Rigatti; E K Novak; M B Gorin; R T Swank
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

5.  Survival and lung pathology of mouse models of Hermansky-Pudlak syndrome and Chediak-Higashi syndrome.

Authors:  M P McGarry; M Reddington; E K Novak; R T Swank
Journal:  Proc Soc Exp Biol Med       Date:  1999-03

6.  New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.

Authors:  Lei Sun; Marisa C Louie; Kevin M Vannella; Carol A Wilke; Ann Marie LeVine; Bethany B Moore; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

7.  CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab.

Authors:  Ganesh Raghu; Fernando J Martinez; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Athol U Wells; Lisa Lancaster; Kevin F Gibson; Tarik Haddad; Prasheen Agarwal; Michael Mack; Bidisha Dasgupta; Ivo P Nnane; Susan K Flavin; Elliot S Barnathan
Journal:  Eur Respir J       Date:  2015-10-22       Impact factor: 16.671

8.  Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Michael T Borchers; Holly L Allen; Reta S Gibbons; Francis X McCormack
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury.

Authors:  John J Osterholzer; Michal A Olszewski; Benjamin J Murdock; Gwo-Hsiao Chen; John R Erb-Downward; Natalya Subbotina; Keely Browning; Yujing Lin; Roger E Morey; Jeremy K Dayrit; Jeffrey C Horowitz; Richard H Simon; Thomas H Sisson
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

10.  Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.

Authors:  Paul F Mercer; Robin H Johns; Chris J Scotton; Malvina A Krupiczojc; Melanie Königshoff; David C J Howell; Robin J McAnulty; Anuk Das; Andrew J Thorley; Terry D Tetley; Oliver Eickelberg; Rachel C Chambers
Journal:  Am J Respir Crit Care Med       Date:  2008-12-05       Impact factor: 21.405

View more
  40 in total

Review 1.  Reactive oxygen species as signaling molecules in the development of lung fibrosis.

Authors:  Francisco J Gonzalez-Gonzalez; Navdeep S Chandel; Manu Jain; G R Scott Budinger
Journal:  Transl Res       Date:  2017-10-10       Impact factor: 7.012

2.  Discoidin Domain Receptor 2, a Potential Therapeutic Target in Lung Fibrosis.

Authors:  Corina M Borza; Ambra Pozzi; Erin J Plosa
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

3.  Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Resat Cinar; Bernadette R Gochuico; Malliga R Iyer; Tony Jourdan; Tadafumi Yokoyama; Joshua K Park; Nathan J Coffey; Hadass Pri-Chen; Gergő Szanda; Ziyi Liu; Ken Mackie; William A Gahl; George Kunos
Journal:  JCI Insight       Date:  2017-04-20

Review 4.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

5.  Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease.

Authors:  Yang Zhou; Chuan Hua He; Daniel S Yang; Tung Nguyen; Yueming Cao; Suchitra Kamle; Chang-Min Lee; Bernadette R Gochuico; William A Gahl; Barry S Shea; Chun Geun Lee; Jack A Elias
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

Review 6.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 7.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 8.  Insights from human genetic studies of lung and organ fibrosis.

Authors:  Christine Kim Garcia
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

9.  Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis.

Authors:  Shin-Ichi Nureki; Yaniv Tomer; Alessandro Venosa; Jeremy Katzen; Scott J Russo; Sarita Jamil; Matthew Barrett; Vivian Nguyen; Meghan Kopp; Surafel Mulugeta; Michael F Beers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

10.  IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge.

Authors:  Brenda F Reader; Shruthi Sethuraman; Bryan R Hay; Rose Viguna Thomas Becket; Manjula Karpurapu; Sangwoon Chung; Yong Gyu Lee; John W Christman; Megan N Ballinger
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.